Mapping the microbiome: could personalized gut bacteria testing transform intestinal care?
NCT ID NCT06845527
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This study aims to characterize the gut microbiome and immune markers of 400 adults visiting a specialized gut microbiota clinic. By analyzing stool and saliva samples alongside blood cytokine profiles, researchers hope to build a database linking microbial patterns to intestinal health. The goal is to better understand how microbiome testing might guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help standardize how gut microbiome testing is used in clinical care, potentially guiding personalized treatments for intestinal disorders.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. The findings may not apply to broader populations outside this single clinic.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRome, RM, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.